| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |